ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.486,21
0,26%
S&P 500
5.187,70
0,13%
Dow Jones
38.884,26
0,08%
Euro vs US Dollar
1,07397
-0,10%
Bitcoin
62.171,68
-0,26%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Eton Pharmaceuticals Inc (ETON)

  7. Eton Pharmaceuticals Inc (ETON) News

ETON

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ETON
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202422h05GlobeNewswire Inc.Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
30/04/202413h00GlobeNewswire Inc.Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
29/04/202422h30GlobeNewswire Inc.Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ETONEton Pharmaceuticals Inc
22/03/202407h00GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaNASDAQ:ETONEton Pharmaceuticals Inc
14/03/202421h01GlobeNewswire Inc.Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
29/02/202422h01GlobeNewswire Inc.Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024NASDAQ:ETONEton Pharmaceuticals Inc
21/02/202412h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
21/02/202412h50GlobeNewswire Inc.Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
02/02/202412h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
02/02/202412h50GlobeNewswire Inc.Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone CapsulesNASDAQ:ETONEton Pharmaceuticals Inc
09/11/202322h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
09/11/202322h01GlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
30/10/202311h50GlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023NASDAQ:ETONEton Pharmaceuticals Inc
18/10/202314h00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
04/10/202312h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
04/10/202312h50GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product NitisinoneNASDAQ:ETONEton Pharmaceuticals Inc
23/08/202312h50GlobeNewswire Inc.Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
10/08/202322h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
10/08/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
10/08/202322h01GlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
01/08/202322h05GlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023NASDAQ:ETONEton Pharmaceuticals Inc
17/07/202322h05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
28/06/202313h42Dow Jones NewsEton Pharma Gets FDA Complete Response Letter for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
28/06/202312h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
28/06/202312h50GlobeNewswire Inc.Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
15/06/202322h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
13/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ETON

Kürzlich von Ihnen besucht

FX
EURJPY
Euro vs Yen
TG
CBK
Commerzbank
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
CCOM
US30
US 30
DBI
TDXP
Tec DAX
TG
BAS
BASF
COIN
ETHUSD
Ethereum
TG
BAYN
Bayer
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
NYSE
MRK
Merck
CCOM
SILVER
SILVER
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten